Connect with us
dyscognitive syndrome
Syndrome postulated by Heinrich as resulting from treatment of schizophrenia with neuroleptic drugs: ambivalence, aphasia, emotional disturbance, impairment of willful direction of thinking, impairment of creativity, and other thought disorder.
04/07/2023 - Epic, Not All Adverse Effects Are Allergic!
11/18/2022 - The Myth of Location
04/14/2022 - "Right" to an In-Person Encounter
09/02/2021 - Half Year, Uh
07/08/2021 - No Freedom of Information at FDA
Daily Tweets
CNS Drug: #CNSDOD
Notable Person: #BHCPOD
Phobia: #BNphobia
Term: #BHCTOD